At baseline, serum levels of effector cytokines (IFN-γ, IL-17 and IL-22) and proinflammatory cytokines (IL-6, TNF-α) were higher in psoriasis patients relative to healthy controls. This evidence concerns the gene IL6 and psoriasis.